BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu W, Tang M, Wang J, Wang L. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:4086864. [PMID: 32148541 DOI: 10.1155/2020/4086864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang X, Tai H, Xiao X, Zhang S, Cui S, Qi S, Hu D, Zhang L, Kuang J, Meng X, Li S. Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.962154] [Reference Citation Analysis]
2 Li J, Zheng R, Lin Z, Hu F, Lin Y, Zeng G, Fang J, Shen Y, Tan H, Han M, Li J. Impact of Chinese Herbal Medicine on Glucolipid Metabolic Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:3245663. [PMID: 36212945 DOI: 10.1155/2022/3245663] [Reference Citation Analysis]
3 Zhang Y, Guo X, Ma S, Ma H, Li H, Wang Y, Qin Z, Wu X, Han Y, Han Y. The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome. Evid Based Complement Alternat Med 2021;2021:6678398. [PMID: 34055020 DOI: 10.1155/2021/6678398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Yu Y, Yang F, Liu H. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids. Biosci Rep 2020;40:BSR20202342. [PMID: 33196098 DOI: 10.1042/BSR20202342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shen W, Jin B, Pan Y, Han Y, You T, Zhang Z, Qu Y, Liu S, Zhang Y. The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome. Evid Based Complement Alternat Med 2021;2021:6619597. [PMID: 33727940 DOI: 10.1155/2021/6619597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Xu J, Xu Y, Zhu Y, Li Z, Wang X. Molecular Targets and Associated Signaling Pathways of Jingshu Granules in Ovarian Cysts Based on Systemic Pharmacological Analysis. Biomed Res Int 2021;2021:6660087. [PMID: 33623786 DOI: 10.1155/2021/6660087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wang C, Ding C, Hua Z, Chen C, Yu J. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators Inflamm 2020;2020:8865647. [PMID: 33299379 DOI: 10.1155/2020/8865647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]